相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Frederick G. Kushner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
CREB activation and ischaemic preconditioning
E. Marais et al.
CARDIOVASCULAR DRUGS AND THERAPY (2008)
PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways
Hyun-Jeong Kwak et al.
CELLULAR SIGNALLING (2008)
Protein kinase D links Gq-coupled receptors to cAMP response element-binding protein (CREB)-Ser133 phosphorylation in the heart
Nazira Ozgen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
Elliott M. Antman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Ralph L. Sacco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation
Ramanna Merla et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin
Yochai Birnbaum et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
被撤回的出版物: Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target (Retracted article. See vol. 53, pg. 743, 2012)
Norbert Nagy et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Signaling pathways regulating murine cardiac CREB phosphorylation
Bailing Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2
S Atar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Dipyridamole, an underestimated vascular protective drug
W Schaper
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Resveratrol-mediated activation of cAMP response element-binding protein through adenosine A3 receptor by Akt-dependent and -independent pathways
S Das et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury
Y Birnbaum et al.
CARDIOVASCULAR RESEARCH (2005)
The reperfusion injury salvage kinase pathway: A common target for both ischemic preconditioning and postconditioning
DJ Hausenloy et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2005)
Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism
J Inserte et al.
CARDIOVASCULAR RESEARCH (2004)
Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C
S Sanada et al.
CIRCULATION (2004)
Diazoxide-mediated preconditioning against apoptosis involves activation of cAMP-response element-binding protein (CREB) and NFκB
RA Eliseev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Optimal windows of statin use for immediate infarct limitation -: 5′-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase
S Sanada et al.
CIRCULATION (2004)
Signalling from adenosine receptors to mitogen-activated protein kinases
G Schulte et al.
CELLULAR SIGNALLING (2003)
Pharmacological stress agents for evaluation of ischemic heart disease
JA Raza et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2001)
Intracoronary administration of dipyridamole prior to percutaneous transluminal coronary angioplasty provides a protective effect exceeding that of ischemic preconditioning
UE Heidland et al.
CORONARY ARTERY DISEASE (2000)
Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: A prospectively randomized trial
UE Heidland et al.
AMERICAN HEART JOURNAL (2000)
Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial
MP Heintzen et al.
HEART (2000)
Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias - Evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias
Y Yoshida et al.
CIRCULATION (2000)
分享论文
